Viva Biotech Holdings is a Shanghai-based company that specializes in structure-based drug discovery services for biotechnology and pharmaceutical clients worldwide. Founded in 2008, the company offers a comprehensive range of research and development services, including fragment-based drug discovery and advanced screening technologies such as affinity selection mass spectrometry and cryo-electron microscopy. Viva Biotech provides various products, including cell lines, crystal structures, GPCR proteins, and antibodies, alongside services in medicinal chemistry, in vitro pharmacology, and antibody discovery. The company operates as an integrated drug discovery platform, combining its expertise in early-stage drug research with contract development and manufacturing services for small molecule active pharmaceutical ingredients and intermediates. Its innovative approach and advanced technological platforms position Viva Biotech as a valuable partner in the global drug development landscape.
COFCO is a leading supplier of agricultural products and services based in Beijing, China. The company operates across various sectors within the agricultural and food industry, focusing on the trade, processing, and distribution of commodities such as grain, edible oils, sugar, and cotton. COFCO plays a crucial role in connecting domestic markets with international suppliers, serving as a key channel for the import and export of bulk agricultural products like wheat, corn, rice, and sugar. The company is committed to utilizing renewable natural resources to provide healthy and nutritious food while enhancing living standards and social prosperity. In addition to its core activities, COFCO is involved in various sectors, including real estate, hospitality, non-grain bio-energy, packaging, and finance, thereby diversifying its business portfolio and contributing to economic growth.
Sironax is a clinical-stage biotechnology company based in Beijing, China, founded in 2017. The company focuses on developing innovative products and treatments for age-related degenerative diseases, concentrating on mechanisms such as regulated cell death, neuroprotective pathways, and neuroinflammation. By researching apoptosis and other cell death pathways, Sironax aims to create advanced pharmaceuticals that can improve the lives of patients suffering from these conditions. Their goal is to transform the treatment landscape for age-related degenerative diseases, benefiting millions of patients and their families globally.
Jaka Robot
Series D in 2022
Jaka Robot is a Shanghai-based company that specializes in the development, engineering, manufacturing, and marketing of industrial robots. Founded in 2014, the company offers a range of products, including the JAKA ZuTM robot, which features a wireless control system compatible with mobile applications. Additionally, Jaka Robot provides JAKA MES for information integration across various factory departments, along with conveyor systems, palletizing robot systems, and liner molding machines. Its clientele spans multiple sectors, including food and beverage, chemical, packaging, electronics, and mechanical processing industries.
Whale provides an omnichannel marketing platform that transforms marketing operations, digitalizes store operations and unifies offline & online brand experiences leveraging AI + IoT + Big Data to “Connect Brands with Customer”. Founded in 2017, Whale has since empowered 1000+ global FMCG, F&B, Fashion and Automotive brands including P&G, Unilever, Starbucks, UNIQLO, ARMANI, Watsons, Xiaomi, Midea, Lotus, POP MART etc. with over 150,000 stores across APAC, enabling brands to embrace the full potential of digital transformation. Equipped with AI capabilities, patented ReID technology and enterprise-grade security, Whale platforms comprising of Space Data Platform (SDP), Whale Marketing Cloud (WMC), Whale Open Platform (WOP) and Whale Analytics, serve as the end-to-end digitalization engine that enables brands to seamlessly engage with each customer. Whale is backed by Temasek Holding, NIO Capital, Source Code Capital, Linear Capital, Alpha Commune, BAI Capital and The Jiangmen, with 6 offices across Singapore, Hangzhou, Shanghai, Beijing and Shenzhen.
XVERSE is a technology company platform that develops 3D user-generated content. It aims to become one of the operating systems (OS) of the true Internet and one of the important content providers. The company is located in Shenzhen, China.
Amber Group
Series B in 2022
Amber Group Limited is a cryptocurrency financial services provider based in Hong Kong, founded in 2015. The company specializes in facilitating the buying and selling of cryptocurrency products and offers a range of services, including yield enhancement, collateralized lending, decentralized finance, execution services, and electronic market making. With a global presence that includes operations in Taipei, Seoul, and Vancouver, Amber Group serves over 200 institutional clients and has traded more than $200 billion across multiple electronic exchanges. It aims to optimize investment flexibility and maximize returns for its clients by leveraging advanced technology and quantitative research. Amber Group is dedicated to delivering a streamlined cryptocurrency finance experience, helping clients build and protect their wealth over the long term.
Xiaohongshu
Series E in 2021
Xiaohongshu, founded in 2013 and based in Shanghai, China, is a lifestyle sharing platform that allows users to share experiences through text, images, and videos. Initially aimed at assisting overseas travelers with shopping, it has transformed into a vibrant community focused on various lifestyle areas, including cosmetics, fashion, food, travel, entertainment, reading, fitness, and childcare. The platform serves as a social e-commerce space where users can post their favorite products, share shopping experiences, and discover global merchandise, particularly in luxury and beauty sectors. By fostering user-generated content, Xiaohongshu encourages a collaborative environment for lifestyle enthusiasts to exchange insights and recommendations.
Edge Medical Robotics
Series C in 2021
Edge Medical Robotics, Inc. is a company that specializes in designing and developing advanced surgical equipment. Founded on May 4, 2017, and based in Longgang, Shenzhen, China, the company is dedicated to researching and promoting cutting-edge medical technology. Its mission focuses on enhancing surgical safety and treatment efficacy, aiming to elevate the overall standards of healthcare. Through a commitment to excellence and precision in product development, Edge Medical Robotics strives to contribute positively to the improvement of social health outcomes.
Momenta
Corporate Round in 2021
Momenta is an autonomous driving startup operating out of Beijing. Its deep-learning-based software in perception, HD semantic mapping, and data-driven path planning enables the realization of full autonomy. Momenta offer multi-level autonomous driving solutions as well as big data products and services. Momenta’s team is composed of experts in computer vision and deep learning, including one of the authors of Faster R-CNN and ResNet, the most popular deep learning network, as well as winners of ImageNet 2015, MS COCO Challenge 2015, and ImageNet 2017. The company is leading the autonomous driving software space with advanced technical competence and a strong commitment to innovation.
Whale provides an omnichannel marketing platform that transforms marketing operations, digitalizes store operations and unifies offline & online brand experiences leveraging AI + IoT + Big Data to “Connect Brands with Customer”. Founded in 2017, Whale has since empowered 1000+ global FMCG, F&B, Fashion and Automotive brands including P&G, Unilever, Starbucks, UNIQLO, ARMANI, Watsons, Xiaomi, Midea, Lotus, POP MART etc. with over 150,000 stores across APAC, enabling brands to embrace the full potential of digital transformation. Equipped with AI capabilities, patented ReID technology and enterprise-grade security, Whale platforms comprising of Space Data Platform (SDP), Whale Marketing Cloud (WMC), Whale Open Platform (WOP) and Whale Analytics, serve as the end-to-end digitalization engine that enables brands to seamlessly engage with each customer. Whale is backed by Temasek Holding, NIO Capital, Source Code Capital, Linear Capital, Alpha Commune, BAI Capital and The Jiangmen, with 6 offices across Singapore, Hangzhou, Shanghai, Beijing and Shenzhen.
HeyTea is a Chinese tea shop that focuses on innovative beverages, particularly cheese-topped tea and fruit tea. Founded in 2012 in an alley by the riverside, the company initially operated under the name ROYALTEA before rebranding to HEYTEA. The franchise offers a diverse range of products, including instant milk tea, fruit tea, and traditional Chinese tea, aimed at providing customers with unique flavor combinations. Through its distinct offerings, HeyTea has established itself as a prominent player in the tea beverage market.
Arrail Dental
Series E in 2021
Arrail Dental International Group Co. Ltd. is a prominent dental services provider based in Beijing, China, specializing in a wide range of oral health care services. Established in 1998, the company operates numerous clinics across major cities, including Beijing, Shanghai, Shenzhen, and Guangzhou, among others. Arrail Dental offers comprehensive services such as endodontics, general dentistry, orthodontics, pediatric dentistry, and periodontics, as well as specialized treatments like implants and tooth whitening. In addition to in-person consultations, the company facilitates online appointment scheduling to enhance accessibility for its clients. Arrail Dental aims to provide high-quality dental care and has developed a network of elite dentists to support its operations.
NewMed Medical
Series C in 2021
NewMed Medical Co., Ltd. is a Shanghai-based company focused on the research, development, manufacture, and marketing of interventional artificial heart valve systems. Established in 2015, the company specializes in producing artificial heart valves and transcather implantation systems designed to replace diseased mitral valves. These innovative products aim to simplify heart valve replacement surgery, thereby reducing treatment risks and facilitating quicker patient recovery while also lowering surgical costs. Through its advancements in medical technology, NewMed Medical contributes to improved outcomes in cardiac care.
GitLab Information Technology (Hubei) Co.
Series A in 2021
Jihu Information Technology (Hubei) Co., Ltd. is referred to as GitLab, adhering to the "Open-core" principle, combining the world's leading DevOps technology with localized self-developed innovation and customized services, is committed to serving Chinese users. Provide a one-stop open and integrated DevOps platform covering the software development life cycle. Jihu GitLab owns the exclusive intellectual property rights and brand authorization of GitLab, Inc. It is updated monthly based on the GitLab EE version, and on this basis, we add our customized features for domestic users. JiHu GitLab is an out-of-the-box, open DevOps platform built from the ground up as a single application for all stages of the DevOps lifecycle enabling Product, Development, QA, Security, and Operations teams to work concurrently on the same project. JiHu GitLab provides a single data store, one user interface, and one permission model across the DevOps lifecycle, accelerating software development lifecycle through industry-leading project management, security, and compliance features. JiHu GitLab is independently developed and operated in China by GitLab Information Technology (Hubei) Co., Ltd. Investors include GitLab Inc., Sequoia CBC and Gaocheng Capital.
Manner is a specialty coffee chain that believes that coffee should be a healthy drink affordable to all people. While insisting on bringing good coffee to every customer, MANNER also takes environmental protection as its own social responsibility. MANNER will reduce 5 yuan for every behavior of bringing non-disposable paper cups to the store to enjoy coffee. The company is headquartered in Shanghai, China.
Furong Xingsheng
Venture Round in 2021
Furong Xingsheng, established in 2009 and headquartered in Changsha, China, operates convenience stores and offers B2B logistics and distribution services. The company's business model revolves around its community shopping platform, Xingsheng Youxuan, which was launched in 2018. This platform sources fresh products and caters to daily household consumer needs through an online ordering and offline pickup system, offering a wide range of fresh produce, groceries, and general merchandise.
Exegenesis Bio
Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
Abbisko Therapeutics
Series D in 2021
Abbisko Therapeutics Co. Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering, developing, and manufacturing innovative immuno-oncology therapies. Founded in 2016 by a team with extensive experience in drug research and management, the company specializes in small molecule therapies for various conditions, including cancer, metabolic diseases, liver diseases, viral infections, and central nervous system disorders. Abbisko's notable products include ABSK011 and ABSK021, which are designed to treat hepatocellular carcinoma, as well as CSF1R, aimed at addressing solid tumors. The company is dedicated to advancing its pipeline of therapeutics to improve patient outcomes in oncology and beyond.
Gracell Biotechnologies
Series C in 2020
Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering and developing cell therapies for cancer treatment. The company’s lead product candidates include GC012F, a dual-target autologous CAR-T therapy for multiple myeloma, and GC019F, which targets adult B cell acute lymphoblastic leukemia and is also being investigated for relapsed or refractory B cell non-Hodgkin’s lymphoma. Additionally, Gracell is developing GC007F for B cell non-Hodgkin's lymphoma and GC027, an allogeneic CAR-T product candidate for adult T cell acute lymphoblastic leukemia. The company also has GC007g, a donor-derived therapy for relapsed or refractory B cell acute lymphoblastic leukemia, and a pipeline of earlier stage candidates targeting other cancer types, including ovarian cancer and breast cancer. Founded in 2017, Gracell aims to provide innovative cellular therapeutics that enhance treatment options for patients suffering from various hematological malignancies and solid tumors.
Yuanfudao
Series G in 2020
Yuanfudao, founded in 2012, is the largest online live course platform in China, catering to primary and secondary school students. With over 1 million paying users, it provides a comprehensive curriculum that includes subjects such as English, Mathematical Olympiad, and various all-subject courses for secondary education. The platform features live online tutoring conducted by nationally recognized teachers, allowing students to receive quality education from home. By utilizing big data analysis, Yuanfudao enables students to identify their learning weaknesses and engage in targeted learning, thus enhancing their educational outcomes. The combination of its extensive course offerings and a large pool of qualified educators benefits hundreds of thousands of students across the country.
JW Therapeutics
Series B in 2020
JW Therapeutics (Shanghai) Co., Ltd. is a biotechnology company based in Shanghai, China, specializing in the development, transformation, and promotion of cell-based immunotherapies. The company focuses on innovative therapies that utilize chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to enhance the body's immune response against cancer. JW Therapeutics is dedicated to creating transformative treatments for both hematological cancers and solid tumors, with its lead product candidate being relmacabtagene autoleucel, a CAR-T therapy targeting anti-CD19. By advancing these groundbreaking therapies, JW Therapeutics aims to improve survival rates and quality of life for cancer patients.
Genor BioPharma
Series B in 2020
Genor BioPharma Co., Ltd. is a biopharmaceutical company based in Shanghai, China, founded in 2007. It specializes in the development and commercialization of therapeutic monoclonal antibodies (mAbs) and Fc-fusion protein drugs, focusing primarily on oncology, autoimmune diseases, and metabolic disorders. The company aims to address significant unmet medical needs through its pipeline, which includes more than ten products, with several already in clinical development. Notable candidates include GB491, an oral CDK4/6 inhibitor; GB221, a novel HER2 mAb; geptanolimab (GB226); and GB242, an infliximab biosimilar. Genor BioPharma also collaborates strategically with Ascentage Pharma to enhance its research and development efforts.
Mininglamp
Series E in 2020
MiningLamp is a rapidly growing startup based in Beijing, China, specializing in big data solutions for enterprises. Founded in 2014, the company focuses on developing advanced artificial intelligence technologies tailored for industries with complex knowledge and management needs. MiningLamp assists clients in building knowledge graphs and applying AI to transform data into actionable insights. Its proprietary big data platform, MDP, offers various products, including Data Insight and Business Intelligence Discovery, which enable clients to analyze and leverage both structured and unstructured data. By integrating perceptual and cognitive intelligence, the company facilitates human-machine collaboration and supports organizations in their digital transformation efforts. MiningLamp has successfully delivered solutions to notable clients, including China UnionPay and CCTV, enhancing their operational efficiency and decision-making capabilities.
Abbisko Therapeutics
Series C in 2020
Abbisko Therapeutics Co. Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering, developing, and manufacturing innovative immuno-oncology therapies. Founded in 2016 by a team with extensive experience in drug research and management, the company specializes in small molecule therapies for various conditions, including cancer, metabolic diseases, liver diseases, viral infections, and central nervous system disorders. Abbisko's notable products include ABSK011 and ABSK021, which are designed to treat hepatocellular carcinoma, as well as CSF1R, aimed at addressing solid tumors. The company is dedicated to advancing its pipeline of therapeutics to improve patient outcomes in oncology and beyond.
Kuaishou Technology
Series F in 2019
Kuaishou Technology, founded in 2011 and based in Beijing, China, operates an online video and photo sharing application known as Kuaishou. The platform enables users to broadcast their daily activities and engage with a global audience through short videos, photos, and live streams. Kuaishou aims to enhance individual happiness by leveraging big data and artificial intelligence technology, promoting equal opportunities through its algorithms and ethical values. The app empowers everyday individuals in China to share their experiences and connect with fans worldwide. Additionally, Kuaishou has an international counterpart, Kwai, which offers similar features tailored for users outside of China. With an average of 275.9 million daily active users, Kuaishou generates revenue by selling virtual items, online marketing, and earning commissions from e-commerce transactions on its platform.
Aier Eye Hospital Group
Post in 2019
Aier Eye Hospital Group Co., Ltd. is a prominent provider of eye care services, operating a network of approximately 200 ophthalmic hospitals in mainland China, along with additional facilities in Europe, the United States, and Hong Kong. Established in 2007 and headquartered in Changsha, China, the company specializes in a range of ophthalmic treatments, including myopia surgery, cataract and glaucoma management, pediatric ophthalmology, and corneal diseases. It also offers optometry services and training courses focused on cataract prevention and treatment. Aier Eye Hospital Group is dedicated to delivering high-standard medical care and advancing ophthalmic technology and management practices in the region.
Gracell Biotechnologies
Series B in 2019
Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering and developing cell therapies for cancer treatment. The company’s lead product candidates include GC012F, a dual-target autologous CAR-T therapy for multiple myeloma, and GC019F, which targets adult B cell acute lymphoblastic leukemia and is also being investigated for relapsed or refractory B cell non-Hodgkin’s lymphoma. Additionally, Gracell is developing GC007F for B cell non-Hodgkin's lymphoma and GC027, an allogeneic CAR-T product candidate for adult T cell acute lymphoblastic leukemia. The company also has GC007g, a donor-derived therapy for relapsed or refractory B cell acute lymphoblastic leukemia, and a pipeline of earlier stage candidates targeting other cancer types, including ovarian cancer and breast cancer. Founded in 2017, Gracell aims to provide innovative cellular therapeutics that enhance treatment options for patients suffering from various hematological malignancies and solid tumors.
Ant Group
Series C in 2018
Ant Group Co., Ltd. is a leading provider of digital payment and financial services in China, known for its flagship product, Alipay, a widely used digital payments platform. Established in 2000 and headquartered in Hangzhou, the company offers a variety of financial solutions, including Yu'e Bao, an online cash management platform that invests users' funds in a money market fund; Huabei, a consumer credit service facilitating buy now, pay later options; and MYbank, an online bank focused on serving small businesses and entrepreneurs. Additionally, Ant Group operates Xiang Hu Bao, a mutual aid platform for health protection, and Zhima Credit, a credit assessment service for businesses. The company aims to foster digital transformation across the service industry, ensuring that consumers and small enterprises have equal access to inclusive and sustainable financial services. In July 2020, it rebranded from Ant Small and Micro Financial Services Group Co., Ltd. to Ant Group Co., Ltd.
Hangzhou Just Biotherapeutics
Series B in 2018
Hangzhou Just Biotherapeutics, also known as Just China, is a biotechnology company founded in 2016 and based in Hangzhou, China. The company focuses on the development of antibody and recombinant protein bio-therapeutics, utilizing advanced molecular and process design techniques. As a subsidiary of MabSpace Biosciences Co., Ltd., Hangzhou Just Biotherapeutics aims to overcome scientific and technical challenges in the field of biologics. Their innovative technology enhances the development process for bio-medicine while significantly lowering manufacturing costs, thereby accelerating the availability of therapeutic solutions.
Innovent Biologics
Series E in 2018
Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacturing, and commercialization of monoclonal antibodies. The company focuses on therapeutic areas such as oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody approved for treating various cancers, including Hodgkin's lymphoma and esophageal carcinoma. Innovent's pipeline includes several important candidates, such as IBI-301, a rituximab biosimilar for non-Hodgkin's lymphoma, and IBI-303, an adalimumab biosimilar for autoimmune diseases. The company is also developing innovative therapies for conditions like hypercholesterolemia and various cancers. With a robust portfolio of commercialized products and ongoing strategic collaborations with major pharmaceutical companies, Innovent aims to expand its impact in the global biopharmaceutical landscape. Founded in 2011, Innovent is recognized as one of China's leading biotechnology firms.
SenseTime
Series C in 2018
SenseTime Group Limited is an artificial intelligence company specializing in computer vision and deep learning technologies. Founded in 2014 and headquartered in Beijing, China, the company develops a wide range of AI solutions, including face and body analysis, image and video recognition, autonomous driving technologies, and medical image analysis. SenseTime's proprietary AI infrastructure, SenseCore, supports scalable and efficient AI software platforms tailored for various applications across sectors such as smart cities, intelligent transportation, healthcare, and finance. The company is also active in advancing industry standards related to data security and ethical AI practices, having contributed to numerous national and international guidelines. With a presence in multiple countries, including Japan, Singapore, and several locations in China, SenseTime aims to drive innovation and foster sustainable productivity through its AI technologies.
17zuoye is an education technology company based in China that provides an online learning platform tailored for K-12 students, teachers, and parents. The name translates to "homework together," reflecting its mission to enhance the educational experience for these groups. The platform focuses primarily on English and Math, offering a comprehensive, multi-platform homework solution that aligns with the textbook curriculum and leverages big data analytics. It equips teachers with effective teaching tools and detailed statistics, while students benefit from engaging learning applications and personalized adaptive content. Parents receive timely study reports to track their children's progress. In addition to its educational services, 17zuoye fosters a community through the largest real-name-based online teachers' forum and a Wechat parent community in China, facilitating collaboration and communication among users.
JW Therapeutics
Series A in 2018
JW Therapeutics (Shanghai) Co., Ltd. is a biotechnology company based in Shanghai, China, specializing in the development, transformation, and promotion of cell-based immunotherapies. The company focuses on innovative therapies that utilize chimeric antigen receptor (CAR) and T cell receptor (TCR) technologies to enhance the body's immune response against cancer. JW Therapeutics is dedicated to creating transformative treatments for both hematological cancers and solid tumors, with its lead product candidate being relmacabtagene autoleucel, a CAR-T therapy targeting anti-CD19. By advancing these groundbreaking therapies, JW Therapeutics aims to improve survival rates and quality of life for cancer patients.
Rokid Technology
Series B in 2018
Rokid Technology, established in 2014, is a California-based company specializing in artificial intelligence and robotics. It develops and manufactures smart devices, including AI-powered smart speakers and augmented reality (AR) smart glasses. Rokid's products, such as the Rokid Glass, incorporate advanced AI capabilities like facial recognition, language translation, and voice control, providing users with an interactive experience by overlaying digital information onto the physical world. The company's offerings cater to both consumer and industrial markets, aiming to enhance human-computer interaction through superior industrial design and user experience.
TrustDecision
Series C in 2017
TrustDecision is a Chinese fintech company established in 2013 and headquartered in Hangzhou. It specializes in developing online software solutions aimed at anti-theft and fraud management across various sectors, including finance, insurance, payments, online shopping, and social networking. By providing risk control services, TrustDecision helps businesses mitigate fraud risks and enhance security in their digital transactions. The company's innovative approach to risk management positions it as a key player in the fintech landscape, catering to the growing demand for effective fraud prevention solutions in an increasingly digital economy.
Hangzhou Just Biotherapeutics
Series B in 2017
Hangzhou Just Biotherapeutics, also known as Just China, is a biotechnology company founded in 2016 and based in Hangzhou, China. The company focuses on the development of antibody and recombinant protein bio-therapeutics, utilizing advanced molecular and process design techniques. As a subsidiary of MabSpace Biosciences Co., Ltd., Hangzhou Just Biotherapeutics aims to overcome scientific and technical challenges in the field of biologics. Their innovative technology enhances the development process for bio-medicine while significantly lowering manufacturing costs, thereby accelerating the availability of therapeutic solutions.
LinkDoc Technology Limited, founded in 2014 and headquartered in Beijing, China, specializes in medical data solutions and oncology-focused big data platforms. The company provides structured clinical data to oncology hospitals, aiding them in addressing various scientific and clinical challenges. Additionally, LinkDoc is committed to ensuring patient privacy and data security, adhering to standards set by the US HIPAA Act. The company focuses on delivering continuous care for patients with critical diseases and offers data-driven solutions that support life sciences companies and healthcare professionals in enhancing clinical research and facilitating real-world application of medical advancements.
Meituan Bike
Private Equity Round in 2017
Meituan Bike, previously known as Mobike, is a Chinese bicycle-sharing service that operates a fully station-less model. Founded in January 2015 by Davis Wang Xiao Feng, Hu Wei Wei, and Xia Yi Ping, the company is headquartered in Beijing. Meituan Bike allows users to easily locate and rent bicycles through a mobile application, facilitating convenient transportation for short urban trips. The bicycles are equipped with smart locks and can be reserved via the app, offering a seamless user experience. In April 2018, the company was acquired by Meituan-Dianping for $2.7 billion and was rebranded as Meituan Bike in January 2019 as part of the integration process. The service has grown significantly since its inception, contributing to the development of urban mobility solutions in China.
Innovent Biologics
Series D in 2016
Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacturing, and commercialization of monoclonal antibodies. The company focuses on therapeutic areas such as oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody approved for treating various cancers, including Hodgkin's lymphoma and esophageal carcinoma. Innovent's pipeline includes several important candidates, such as IBI-301, a rituximab biosimilar for non-Hodgkin's lymphoma, and IBI-303, an adalimumab biosimilar for autoimmune diseases. The company is also developing innovative therapies for conditions like hypercholesterolemia and various cancers. With a robust portfolio of commercialized products and ongoing strategic collaborations with major pharmaceutical companies, Innovent aims to expand its impact in the global biopharmaceutical landscape. Founded in 2011, Innovent is recognized as one of China's leading biotechnology firms.
Nio is a Chinese electric vehicle manufacturer that designs, manufactures, and sells premium smart electric vehicles globally. Founded in 2014, Nio offers a range of SUVs with varying seating capacities, along with innovative charging solutions such as battery swapping services and mobile charging trucks. The company also provides value-added services like insurance packages, maintenance, and roadside assistance. Nio collaborates with industry leaders for autonomous driving technologies and manufactures its vehicles through strategic partnerships. As of 2023, Nio has sold over 160,000 electric vehicles in China alone, capturing approximately 2% of the market share for new energy passenger vehicles.
Alibaba Group
Post in 2016
Alibaba Group is the largest online and mobile commerce company globally, primarily known for its extensive e-commerce platforms that connect buyers and sellers. It operates notable marketplaces in China, including Taobao, which focuses on consumer-to-consumer transactions, and Tmall, which caters to business-to-consumer interactions. The company's core business lies in its China commerce retail division, which is a significant source of cash flow. In addition to retail and wholesale transactions, Alibaba also generates revenue from various sectors, including international commerce, local consumer services, cloud computing, digital media and entertainment, and logistics through its Cainiao network. Alibaba's diverse portfolio positions it as a key player across multiple industries, including retail, logistics, and technology.
G7 is a company that specializes in fleet management systems aimed at optimizing the transportation ecosystem. With a significant installation base of 800,000 cargo vehicles across China, G7 utilizes proprietary hardware devices to gather and analyze data for logistics companies and drivers. The company's platform enables businesses to locate and monitor transportation vehicles, track driver behaviors, and estimate departure and arrival times. Additionally, G7 provides detailed insights on route optimization, fuel consumption, and cargo conditions, such as temperature and humidity, which helps corporate clients and business owners enhance the efficiency of their transportation networks.
Cainiao Logistics
Series A in 2016
Cainiao Logistics provides logistics services to Alibaba Group. It operates warehouses and express delivery stations. Cainiao Logistics also operates a logistics information platform which provides real-time access to information for both buyers and sellers. Shen Guojun founded China Smart Logistics Network on May 28, 2013 that later became Cainiao Logistics, with its headquarters in Shenzhen in China.
Meituan
Venture Round in 2016
Meituan, established in 2010 and headquartered in Beijing, China, operates a comprehensive online platform offering retail and group buying services. It specializes in delivering Chinese food from local restaurants and provides online group discounts for a wide range of sectors, including movies, groceries, restaurants, entertainment, and health/fitness. As of 2020, Meituan holds a dominant 70.7% share in China's food delivery market. Its revenue streams are primarily derived from on-demand services (58%), hotel booking, coupon sales, and advertising (17%), with new initiatives contributing the remaining 25%. These new initiatives, such as community group buying and non-food delivery, are poised to transform Meituan into a broader grocer and logistics business, potentially surpassing food delivery as its primary focus.
iTutorGroup
Series C in 2015
iTutorGroup is an online education provider founded in 1998, headquartered in Taipei City, Taiwan, with additional offices in Shanghai, China, and Santa Clara, California. The company offers a range of platforms designed for both students and business professionals, including VIPABC, TutorABC, VIPABCJr, and TutorABCJr for English language learning, as well as TutorMing for Mandarin Chinese language instruction. Additionally, iTutorGroup provides LiveH2H, a service for live translations in multiple languages. The company focuses on delivering individualized and personalized learning experiences, allowing instructors to tailor content to meet the specific needs of learners.
Iwjw is a company that provides an online platform for house rental services, facilitating a connection between prospective clients and property listings. The platform allows users to book appointments for in-person visits to various properties. Founded in 2014, Iwjw is headquartered in Shanghai, China, and focuses on enhancing the rental experience by bridging online searches with offline property viewing.
Tuniu Corporation is an online leisure travel company based in Nanjing, China, founded in 2006. It specializes in offering a wide array of packaged tours, including organized and self-guided options, tailored for leisure travelers. The company provides comprehensive travel-related services such as ticket sales for tourist attractions, visa applications, accommodation reservations, and transportation options, including air, train, and bus tickets. Tuniu also offers car rental and insurance services, along with advertising solutions for tourism boards. The company's products and services are accessible through its website, mobile platform, and a network of offline channels, which includes call centers and retail stores across China. With over 550,000 stock keeping units covering more than 140 countries, Tuniu aims to enhance customer experience and expand its market presence by diversifying its offerings and investing in technology.
17zuoye is an education technology company based in China that provides an online learning platform tailored for K-12 students, teachers, and parents. The name translates to "homework together," reflecting its mission to enhance the educational experience for these groups. The platform focuses primarily on English and Math, offering a comprehensive, multi-platform homework solution that aligns with the textbook curriculum and leverages big data analytics. It equips teachers with effective teaching tools and detailed statistics, while students benefit from engaging learning applications and personalized adaptive content. Parents receive timely study reports to track their children's progress. In addition to its educational services, 17zuoye fosters a community through the largest real-name-based online teachers' forum and a Wechat parent community in China, facilitating collaboration and communication among users.
InnoVen Capital
Acquisition in 2015
InnoVen Capital is a prominent venture lending firm based in Mumbai, India, with additional offices in Singapore and Beijing. Established in 2008, it was re-branded following a buyout by Temasek Holdings and UOB Group in 2015. As the first and largest venture debt provider in India, InnoVen Capital specializes in offering debt financing to high-growth and innovative technology startups across various growth stages and sectors. The firm has a strong credit rating, reflecting its financial stability and reliability. InnoVen Capital has facilitated over 190 loans to more than 150 startups throughout India and Southeast Asia, providing a range of debt capital solutions, including venture debt, acquisition finance, growth loans, and syndication.
Innovent Biologics
Series C in 2015
Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacturing, and commercialization of monoclonal antibodies. The company focuses on therapeutic areas such as oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody approved for treating various cancers, including Hodgkin's lymphoma and esophageal carcinoma. Innovent's pipeline includes several important candidates, such as IBI-301, a rituximab biosimilar for non-Hodgkin's lymphoma, and IBI-303, an adalimumab biosimilar for autoimmune diseases. The company is also developing innovative therapies for conditions like hypercholesterolemia and various cancers. With a robust portfolio of commercialized products and ongoing strategic collaborations with major pharmaceutical companies, Innovent aims to expand its impact in the global biopharmaceutical landscape. Founded in 2011, Innovent is recognized as one of China's leading biotechnology firms.
VNET Group is a prominent internet data center services provider based in Beijing, China. Established in 1996, the company initially operated as AsiaCloud before transitioning to the data center sector with its first self-developed facility opening in 2010. VNET Group specializes in a range of services, including colocation, cloud computing, and managed network services, designed to enhance the reliability, security, and speed of internet connections for its clients. Over the years, the company has expanded its clientele to include major Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud. As of March 2024, VNET Group operates 48,503 self-built retail cabinets, primarily located in key regions like Beijing, Shanghai, and the Greater Bay area, along with 332 megawatts of wholesale power capacity, solidifying its position as a leading player in the data center market in China.
Chunyu Yisheng
Series C in 2014
Chunyu Yisheng is a mobile application that enables physicians and their patients to communicate with each other. The application provides physicians with access to their patients’ medical records. Furthermore, it enables the patients to communicate and schedule appointments with the doctors. In addition, it offers reservation line treatment services to its users. Chunyu Yisheng was launched in 2011 by Rui Zhang and is based in Beijing.
Shanghai Yupei Group
Private Equity Round in 2014
Shanghai Yupei (Group) was founded in 2000 and headquartered in Shanghai, which is a private company that specialized in the development, operation and management of logistics warehousing facilities. The Company takes strategic cooperation, network distribution, specialized and build-to-suit projects as the development strategies, and the company implements the business philosophy of meeting customer needs and creating value for customers to achieve the strategic goal of creating a world leading logistics and warehousing property brand, and being the largest logistics and warehousing property developer. With more than ten years of experience in the development of logistics facilities, the Company has established a scientific internal management mechanism and a harmonious and efficient enterprise culture, possessed an outstanding team proficient in product design, development and construction. Additionally, in collaboration with international well-known estate investment companies , has introduced advanced enterprise management, product development ideas and strong financial strength to the Company. Relying on the above advantages and abundant capital resource, the Company commit to provide customers with high-quality standard warehousing facilities as well as build-to-suit products based on customers' special requirements.
VANCL is an online retailer based in Beijing, China, specializing in a wide range of apparel, accessories, footwear, and textiles. Founded in 2007 by Chen Nian, the company offers a diverse selection of products, including shirts, dresses, pants, shoes, and various accessories such as bags, scarves, and sunglasses. By focusing on modern styles at competitive prices, VANCL aims to provide customers with high-quality clothing options. In addition to its online presence, the company operates physical stores, enhancing its accessibility to consumers.
iTutorGroup
Series B in 2014
iTutorGroup is an online education provider founded in 1998, headquartered in Taipei City, Taiwan, with additional offices in Shanghai, China, and Santa Clara, California. The company offers a range of platforms designed for both students and business professionals, including VIPABC, TutorABC, VIPABCJr, and TutorABCJr for English language learning, as well as TutorMing for Mandarin Chinese language instruction. Additionally, iTutorGroup provides LiveH2H, a service for live translations in multiple languages. The company focuses on delivering individualized and personalized learning experiences, allowing instructors to tailor content to meet the specific needs of learners.
VNET Group is a prominent internet data center services provider based in Beijing, China. Established in 1996, the company initially operated as AsiaCloud before transitioning to the data center sector with its first self-developed facility opening in 2010. VNET Group specializes in a range of services, including colocation, cloud computing, and managed network services, designed to enhance the reliability, security, and speed of internet connections for its clients. Over the years, the company has expanded its clientele to include major Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud. As of March 2024, VNET Group operates 48,503 self-built retail cabinets, primarily located in key regions like Beijing, Shanghai, and the Greater Bay area, along with 332 megawatts of wholesale power capacity, solidifying its position as a leading player in the data center market in China.
Tuniu Corporation is an online leisure travel company based in Nanjing, China, founded in 2006. It specializes in offering a wide array of packaged tours, including organized and self-guided options, tailored for leisure travelers. The company provides comprehensive travel-related services such as ticket sales for tourist attractions, visa applications, accommodation reservations, and transportation options, including air, train, and bus tickets. Tuniu also offers car rental and insurance services, along with advertising solutions for tourism boards. The company's products and services are accessible through its website, mobile platform, and a network of offline channels, which includes call centers and retail stores across China. With over 550,000 stock keeping units covering more than 140 countries, Tuniu aims to enhance customer experience and expand its market presence by diversifying its offerings and investing in technology.
Cloudary
Private Equity Round in 2013
Cloudary Corporation operates as a provider of literature and publishing services in the People's Republic of China. The company manages an online, community-driven literary platform featuring six original literature websites, including Qidian.com, Readnovel.com, and Hongxiu.com, which cater to various genres such as fantasy, wuxia, science fiction, mystery, and romance. In addition to its extensive collection of literary works, Cloudary offers community engagement tools that include personal spaces, virtual gifting, a book review bar, and forums, fostering interaction among readers and writers. Through a combination of online channels and offline publications, Cloudary aims to enhance the accessibility of literature while building a vibrant literary community.
Xiaomi Technology
Series C in 2012
Xiaomi Corporation, founded in 2010 and headquartered in Beijing, China, is a prominent technology company that designs, manufactures, and markets smartphones and consumer electronics. The company's product range includes a variety of mobile devices, such as Android-based smartphones and smart home products, like smart TVs, AI speakers, and smart routers. Xiaomi is notable for its innovative approach, often incorporating user feedback into product development, which has fostered a loyal customer base. The company operates through several segments, including smartphones, Internet of Things (IoT) products, and Internet services, offering both hardware and software solutions. Additionally, Xiaomi engages in the retail and wholesale of its products, operates service centers, and has expanded its presence internationally, becoming a leader in markets such as India and gaining traction in Europe. With a commitment to providing quality technology at accessible prices, Xiaomi continues to innovate and adapt within the competitive landscape of the tech industry.
Xiaomi Technology
Series B in 2011
Xiaomi Corporation, founded in 2010 and headquartered in Beijing, China, is a prominent technology company that designs, manufactures, and markets smartphones and consumer electronics. The company's product range includes a variety of mobile devices, such as Android-based smartphones and smart home products, like smart TVs, AI speakers, and smart routers. Xiaomi is notable for its innovative approach, often incorporating user feedback into product development, which has fostered a loyal customer base. The company operates through several segments, including smartphones, Internet of Things (IoT) products, and Internet services, offering both hardware and software solutions. Additionally, Xiaomi engages in the retail and wholesale of its products, operates service centers, and has expanded its presence internationally, becoming a leader in markets such as India and gaining traction in Europe. With a commitment to providing quality technology at accessible prices, Xiaomi continues to innovate and adapt within the competitive landscape of the tech industry.
Alibaba Group
Private Equity Round in 2011
Alibaba Group is the largest online and mobile commerce company globally, primarily known for its extensive e-commerce platforms that connect buyers and sellers. It operates notable marketplaces in China, including Taobao, which focuses on consumer-to-consumer transactions, and Tmall, which caters to business-to-consumer interactions. The company's core business lies in its China commerce retail division, which is a significant source of cash flow. In addition to retail and wholesale transactions, Alibaba also generates revenue from various sectors, including international commerce, local consumer services, cloud computing, digital media and entertainment, and logistics through its Cainiao network. Alibaba's diverse portfolio positions it as a key player across multiple industries, including retail, logistics, and technology.
VANCL is an online retailer based in Beijing, China, specializing in a wide range of apparel, accessories, footwear, and textiles. Founded in 2007 by Chen Nian, the company offers a diverse selection of products, including shirts, dresses, pants, shoes, and various accessories such as bags, scarves, and sunglasses. By focusing on modern styles at competitive prices, VANCL aims to provide customers with high-quality clothing options. In addition to its online presence, the company operates physical stores, enhancing its accessibility to consumers.
Huaneng Renewables
Post in 2011
Huaneng Renewables Corporation Limited is a Chinese company focused on the development and operation of renewable energy projects, primarily in wind and solar energy. Established in November 2002, the company has constructed ten wind power plants and six wind power bases across various regions in China, including Northeast China and Sinkiang. Huaneng Renewables has been recognized for its quality engineering in the power sector and has pioneered several significant projects, such as the first domestic wind testing field and the first large-scale field using domestic equipment. The company invests in, constructs, acquires, and operates renewable energy facilities, generating most of its revenue from electricity sales produced at its wind and solar power plants. Huaneng Renewables is a wholly-owned subsidiary of Huaneng Group, a major state-owned electric utility company in China.
Tudou Holdings
Series D in 2010
Tudou is a Chinese video sharing website launched in 2005 by Wang Tei, designed to empower young users to express their creativity through video content. The platform allows users to watch, upload, rate, share, comment on, and recommend a variety of videos, including user-generated content, licensed material, and original programming. In 2012, Tudou merged with Youku, creating a dominant player in the online video market under the name Youku Tudou, Inc. This merger significantly enhanced the user base, with monthly unique visitors increasing from approximately 182 million in late 2010 to about 227 million by mid-2013, outpacing competitors like Sohu, PPTV, and iQiyi. Tudou's focus on engaging and interactive experiences has made it a key platform for independent video producers in China.
Harbour Networks Holdings
Series C in 2005
Harbour Networks Holdings was acquired by Huawei Technologies Co. Ltd. The company provides Internet protocol-based networking equipment. The company offers Ethernet switches, IP core and edge routers, broadband access equipment, voice over Internet protocol products, optical transport platforms, and networking and services management software, as well as ADSL/VDSL broadband access equipment and NGN integrated access equipment. It serves telecom carriers, corporations, education and government institutions, government agencies, finance, power, and service industries in China, North America, Japan, Hong Kong, and Southeast Asia. The company was founded in 2000 and is based in Beijing, China. As of September 11, 2006, Harbour Networks Holdings Limited operates as a subsidiary of Huawei Technologies Co., Ltd.
Semiconductor Manufacturing International
Series C in 2003
Semiconductor Manufacturing International Corporation (SMIC) is a leading semiconductor foundry based in Shanghai, China, established in 2000. It specializes in the design and manufacturing of integrated circuits (IC) and offers a comprehensive range of services including computer-aided design, wafer fabrication, testing, packaging, and assembly. SMIC operates advanced fabrication facilities, including 300mm and 200mm fabs in various locations such as Beijing, Tianjin, and Shenzhen, and provides technology services for process nodes ranging from 0.35 microns to 28 nanometers. The company serves a diverse clientele, including integrated device manufacturers, fabless semiconductor firms, and system companies, with its products utilized in sectors such as artificial intelligence, data centers, automotive, consumer electronics, and the Internet of Things. SMIC is recognized as the largest foundry in China and ranks fifth globally in the semiconductor industry, employing over 20,200 people and maintaining a presence in markets across North America, Europe, Japan, and Taiwan.
Momenta is an autonomous driving startup operating out of Beijing. Its deep-learning-based software in perception, HD semantic mapping, and data-driven path planning enables the realization of full autonomy. Momenta offer multi-level autonomous driving solutions as well as big data products and services. Momenta’s team is composed of experts in computer vision and deep learning, including one of the authors of Faster R-CNN and ResNet, the most popular deep learning network, as well as winners of ImageNet 2015, MS COCO Challenge 2015, and ImageNet 2017. The company is leading the autonomous driving software space with advanced technical competence and a strong commitment to innovation.
Whale provides an omnichannel marketing platform that transforms marketing operations, digitalizes store operations and unifies offline & online brand experiences leveraging AI + IoT + Big Data to “Connect Brands with Customer”. Founded in 2017, Whale has since empowered 1000+ global FMCG, F&B, Fashion and Automotive brands including P&G, Unilever, Starbucks, UNIQLO, ARMANI, Watsons, Xiaomi, Midea, Lotus, POP MART etc. with over 150,000 stores across APAC, enabling brands to embrace the full potential of digital transformation. Equipped with AI capabilities, patented ReID technology and enterprise-grade security, Whale platforms comprising of Space Data Platform (SDP), Whale Marketing Cloud (WMC), Whale Open Platform (WOP) and Whale Analytics, serve as the end-to-end digitalization engine that enables brands to seamlessly engage with each customer. Whale is backed by Temasek Holding, NIO Capital, Source Code Capital, Linear Capital, Alpha Commune, BAI Capital and The Jiangmen, with 6 offices across Singapore, Hangzhou, Shanghai, Beijing and Shenzhen.